MDXG

MiMedx Announces $10 Million Stock Repurchase Program

[PR Newswire] – MARIETTA, Ga., May 12, 2014 /PRNewswire/ — MiMedx Group, Inc. (MDXG), an integrated developer, manufacturer and marketer of patent-protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced toda moreView todays social media effects on MDXGView the latest stocks trending across Twitter. Click to view dashboardSee who MiMedx is hiring next, click here to view […]

4:46 pm MiMedx Group announces two of its peer-reviewed scientific studies have been published in the scientific literature; MiMedx PURION Processed dHACM may stimulate angiogenesis when applied to a wound

moreView todays social media effects on MDXGView the latest stocks trending across Twitter. Click to view dashboardSee who MiMedx is hiring next, click here to view […]

Two New MiMedx Scientific Studies Published In Peer-Reviewed Journals

[PR Newswire] – MARIETTA, Ga., May 6, 2014 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG) , an integrated developer, manufacturer and marketer of patent-protected regenerative biomaterials and bioimplants processed … moreView todays social media effects on MDXGView the latest stocks trending across Twitter. Click to view dashboardSee who MiMedx is hiring next, click here to view […]

4:44 pm MiMedx Group issued four new U.S. patents for placental tissue allografts; co amends its patent infringement lawsuit to include two additional patents

moreView todays social media effects on MDXGView the latest stocks trending across Twitter. Click to view dashboardSee who MiMedx is hiring next, click here to view […]

8:38 am MiMedx Group will hold a call tmrw at 11:00 for business update; co raises low end of 2014 rev guidance; March results indicate wound care centers have absorbed CMS chages

moreView todays social media effects on MDXGView the latest stocks trending across Twitter. Click to view dashboardSee who MiMedx is hiring next, click here to view […]